Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) reported Q3 CY2025 results , but sales fell by 5.7% ...

Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the low priced stocks to buy with high upside potential. On December 12, Bank ...

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of ...

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable ...

When it comes to migraines, not all headaches are created the same. According to Joey Gee, D.O., neurologist with Providence Mission Hospital, approximately 15 to 25% of migraine sufferers will ...

The Pooled Cohort Equations (PCE) cardiovascular risk score stratifies risk for multiple ocular diseases, according to a ...

Aim Previous surveys of ocular disease in leukaemia patients have shown the retina, choroid, and orbit as the most commonly involved sites. Depending on the type of leukaemia and the study design, the ...

Ocular TB is a rare eye disease due to infection from Mycobacterium tuberculosis, the same bacterium that causes tuberculosis, commonly known as TB. TB symptoms usually start in the lungs, but they ...

Ocular migraine is associated with visual disturbances and may be related to genetics, as research suggests a significant genetic component in migraine. Hormonal fluctuations, particularly drops in ...